Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Equity / Common Stock, par value $1.00 per share
-
Shares outstanding
-
7,356,372
-
Number of holders
-
23
-
Total 13F shares, excl. options
-
2,242,065
-
Shares change
-
-168,360
-
Total reported value, excl. options
-
$10,760,915
-
Value change
-
-$869,931
-
Number of buys
-
6
-
Number of sells
-
-13
-
Price
-
$4.80
Significant Holders of HARTE HANKS INC - Common Stock, par value $1.00 per share (HHS) as of Q1 2025
26 filings reported holding HHS - HARTE HANKS INC - Common Stock, par value $1.00 per share as of Q1 2025.
HARTE HANKS INC - Common Stock, par value $1.00 per share (HHS) has 23 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 2,242,065 shares
of 7,356,372 outstanding shares and own 30% of the company stock.
Largest 10 shareholders include BLAIR WILLIAM & CO/IL (660,845 shares), WESTERLY CAPITAL MANAGEMENT, LLC (618,226 shares), VANGUARD GROUP INC (297,342 shares), Krilogy Financial LLC (132,000 shares), UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC (117,500 shares), GEODE CAPITAL MANAGEMENT, LLC (65,493 shares), RENAISSANCE TECHNOLOGIES LLC (49,284 shares), DIMENSIONAL FUND ADVISORS LP (48,008 shares), ACADIAN ASSET MANAGEMENT LLC (42,107 shares), and BRIDGEWAY CAPITAL MANAGEMENT, LLC (40,846 shares).
This table shows the top 23 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.